Skip to main content

Table. Efficacy of sacubitril/valsartan compared to enalapril in chronic heart failure .

Outcome Sacubitril/valsartan 97/103 mg twice daily Enalapril 10 mg twice daily
Composite primary outcome:
death from cardiovascular causes or hospitalisation from worsening heart failure
21.5% (914/4187) 26.5% (1117/4212)
Death from cardiovascular causes 13.3% (558/4187) 16.5% (693/4212)
Hospitalisation from worsening heart failure 12.8% (537/4187) 15.6% (658/4212)

Source: Reference 2